Section 412(f)(2) of the Federal Food,
Drug, and Cosmetic Act (the act) (21 U.S.C. 350a(f)(2)) states that
the Secretary shall by regulation prescribe the scope and extent of
recalls of infant formula necessary and appropriate for the degree
of risk to human health presented by the formula subject to recall.
FDA's infant formula recall regulations in part 107 (21 CFR part
107) implement these statutory provisions. Sections 107.230 and
107.240 require each recalling firm to conduct an infant formula
recall with specified elements. Before terminating a recall, the
recalling firm is required to submit a recommendation for
termination of the recall to the appropriate FDA district office
and wait for written FDA concurrence (§ 107.250). Where the recall
strategy or implementation is determined to be deficient, FDA may
require the firm to change the extent of the recall, carry out
additional effectiveness checks, and issue additional notifications
(§ 107.260). In addition, to facilitate location of the product
being recalled, the recalling firm is required to maintain
distribution records for at least 1 year after the expiration of
the shelf life of the infant formula (§ 107.280).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.